# US 2024/0269289 A1 · Biodegradable lipids for the delivery of active agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0269289 A1
- Document ID: US20240269289A1
- Status: Published application
- Kind: A1
- Application number: 18/589,688
- Filed: 2024-02-28
- Published: 2024-08-15
- Earliest claimed: 2011-12-07
- Assignees: Alnylam Pharmaceuticals, Inc.
- Applicants: Alnylam Pharmaceuticals, Inc.
- Inventors: Martin MAIER; Muthusamy JAYARAMAN; Akin AKINC; Shigeo MATSUDA; Pachamuthu KANDASAMY; Kallanthottathil G. RAJEEV; Muthiah MANOHARAN; Jayaprakash K. NAIR; Thomas A. BAILLIE
- Web page: https://patentgrep.com/patent/US20240269289A1

## CPC

- A61K 47/18: Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K 9/1272: comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers (lipids as modifying agents {A61K47/543})
- A61K 9/5123: {Organic compounds, e.g. fats, sugars}
- A61K 31/7088: Compounds having three or more nucleosides or nucleotides
- A61K 31/7105: Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
- A61K 31/713: Double-stranded nucleic acids or oligonucleotides
- C07C 31/125: containing five to twenty-two carbon atoms
- C07C 211/09: Diamines
- C07C 211/10: Diaminoethanes
- C07C 211/11: Diaminopropanes
- C07C 217/08: the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
- C07C 229/12: to carbon atoms of acyclic carbon skeletons
- C07C 235/06: having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C 251/38: to carbon atoms of a saturated carbon skeleton
- C07C 323/12: the carbon skeleton being acyclic and saturated
- C07C 323/58: with amino groups bound to the carbon skeleton
- C07C 327/22: having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C 327/28: having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
- C07C 327/32: having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C07D 207/32: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 233/54: having two double bonds between ring members or between ring members and non-ring members
- C07D 295/08: substituted by singly bound oxygen or sulfur atoms
- C07D 295/12: substituted by singly or doubly bound nitrogen atoms (nitro radicals C07D295/06)
- C07D 295/14: substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 317/30: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07F 5/022: {without C-boron linkages}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.

## Claims

### Claim at position 1

1-30. (canceled)

### Claim 31

A lipid consisting of a protonatable primary group and two hydrophobic tails that are directly bonded to the primary group, wherein
each of the two hydrophobic tails:
(i) is of the formula -(hydrophobic chain)-(biodegradable group)-(hydrophobic chain), wherein the biodegradable group is —C(O)O—;
(ii) has a total carbon atom content of from 17 to 26 carbon atoms; and
(iii) the number of carbon atoms between the primary group and the biodegradable group is 5 to 10,
the lipid has a log P of at least 10.1 and a pKa of 4 to 8, and
at least one hydrophobic tail is of the formula:
wherein R13 is a C13-C17 alkyl, the maximum length of R13 from its attachment point to the ester group is 12 carbon atoms, and R13 comprises (i) a carbon atom that is directly bonded to the ester; (ii) two alkyl groups that are directly bonded to the carbon atom that is bonded to the ester; and (iii) a hydrogen atom that is bonded to the carbon atom that is bonded to the ester.

### Claim 32 (depends on 31)

The lipid of claim 31, wherein the lipid has a pKa of 5 to 6.5.

### Claim 33 (depends on 31)

The lipid of claim 31, wherein the primary group consists of a head group and a central moiety, the central moiety is a nitrogen atom, and both hydrophobic tails are directly bonded to the central moiety.

### Claim 34 (depends on 33)

The lipid of claim 33, wherein the maximum length of R13 from its attachment point to the ester group is 11 carbon atoms.

### Claim 35 (depends on 33)

The lipid of claim 33, wherein the ester group in each hydrophobic tail is separated from a terminus of the hydrophobic tail by from 8 to 12 carbon atoms.

### Claim 36 (depends on 33)

The lipid of claim 33, wherein R13 is a C17 alkyl.

### Claim 37 (depends on 33)

The lipid of claim 33, wherein the head group consists of a saturated aliphatic group and a hydroxyl group.

### Claim 38 (depends on 37)

The lipid of claim 37, wherein the saturated aliphatic group is a saturated straight chain alkyl group, wherein the saturated straight chain alkyl group is a methyl, ethyl, n-propyl, n-butyl, n-pentyl, or n-hexyl group.

### Claim 39 (depends on 33)

The lipid of claim 33, wherein the ester group in the at least one hydrophobic tail is separated from a terminus of the tail by 6 to 8 carbon atoms.

### Claim 40 (depends on 33)

The lipid of claim 33, wherein the ester group in the at least one hydrophobic tail is separated from a terminus of the tail by 8 carbon atoms.

### Claim 41 (depends on 40)

The lipid of claim 40, wherein the two hydrophobic tails have different chemical formulas.

### Claim 42 (depends on 41)

The lipid of claim 41, wherein both hydrophobic tails have a chain length of 18 atoms.

### Claim 43 (depends on 42)

The lipid of claim 42, wherein, in the other hydrophobic tail, each hydrophobic chain is a saturated straight chain alkyl group.

### Claim 44 (depends on 33)

The lipid of claim 33, wherein a protonatable group of the protonatable primary group is positively charged at a pH that is below pH 7.4, and neutral at a second pH that is at or above pH 7.4.

### Claim 45

A lipid consisting of a protonatable primary group and two hydrophobic tails directly bonded to the primary group, wherein:
the primary group consists of a head group and a central moiety; and
the central moiety is a nitrogen atom, wherein:
a) both of the two hydrophobic tails have a chain length of 18 atoms;
b) each of the two hydrophobic tails
(i) is of the formula: -(hydrophobic chain)-(C(O)O)-(hydrophobic chain), and
(ii) has a total carbon atom content of from 17 to 26 carbon atoms, and
c) at least one of the two hydrophobic tails has the formula:
wherein R13 is a C17 alkyl, wherein the maximum length of R13 from its attachment point to the ester group is 11 carbon atoms.

### Claim 46 (depends on 45)

The lipid of claim 45, wherein the two hydrophobic tails have different chemical formulas.

### Claim 47 (depends on 45)

The lipid of claim 45, wherein, in the other hydrophobic tail, each hydrophobic chain is a saturated straight chain alkyl group.

### Claim 48 (depends on 46)

The lipid of claim 46, wherein, in the other hydrophobic tail, the number of carbon atoms in the hydrophobic chain between the primary group and the biodegradable group is 5 to 10.

### Claim 49 (depends on 45)

The lipid of claim 45, wherein, the head group consists of a saturated aliphatic group and a hydroxyl group,

### Claim 50 (depends on 49)

The lipid of claim 49, wherein the saturated aliphatic group is a saturated straight chain alkyl group, wherein the saturated straight chain alkyl group is a methyl, ethyl, n-propyl, n-butyl, n-pentyl, or n-hexyl group.

### Claim 51 (depends on 45)

The lipid of claim 45, wherein the other hydrophobic tail has a total carbon atom content of 17 carbon atoms.

### Claim 52 (depends on 45)

The lipid of claim 45, wherein a protonatable group of the protonatable primary group is positively charged at a pH that is below pH 7.4, and neutral at a second pH that is at or above pH 7.4.
